Juvenile ovarian granulosa cell tumor: a benign or malignant condition?

References

• Young R H, Dickersin G R, Scully R E. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 1984; 8: 575–596
   PubMed Web of Science ®Google Scholar
• Schumer S T, Cannistra S A. Granulosa cell tumor of the ovary. J Clin Oncol 2003; 21: 1180–1189
   PubMed Web of Science ®Google Scholar
• Scully R E. Juvenile granulosa cell tumor. Pediatr Pathol 1988; 8: 423–427
   PubMedGoogle Scholar
• Calaminus G, Wessalowski R, Harms D, Gobel U. Juvenile granulosa cell tumors of the ovary in children and adolescents: results from 33 patients registered in a prospective cooperative study. Gynecol Oncol 1997; 65: 447–452
   PubMed Web of Science ®Google Scholar
• Kalfa N, Patte C, Orbach D, Lecointre C, Pienkowski C, Philippe F, Thibault E, Plantaz D, Brauner R, Rubie H, et al. A nationwide study of granulosa cell tumors in pre- and postpubertal girls: missed diagnosis of endocrine manifestations worsens prognosis. J Pediatr Endocrinol Metab 2005; 18: 25–31
   PubMed Web of Science ®Google Scholar
• Cronje H S, Niemand I, Bam R H, Woodruff J D. Granulosa and theca cell tumors in children: a report of 17 cases and literature review. Obstet Gynecol Surv 1998; 53: 240–247
   PubMedGoogle Scholar
• Vassal G, Flamant F, Caillaud J M, Demeocq F, Nihoul-Fekete C, Lemerle J. Juvenile granulosa cell tumor of the ovary in children: a clinical study of 15 cases. J Clin Oncol 1988; 6: 990–995
   PubMed Web of Science ®Google Scholar
• Gribbon M, Ein S H, Mancer K. Pediatric malignant ovarian tumors: a 43-year review. J Pediatr Surg 1992; 27: 480–484
   PubMed Web of Science ®Google Scholar
• Robertson D M, Burger H G, Fuller P J. Inhibin/activin and ovarian cancer. Endocr Relat Cancer 2004; 11: 35–49
   PubMed Web of Science ®Google Scholar
• Pankratz E, Boyes D A, White G W, Galliford B W, Fairey R N, Benedet J L. Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol 1978; 52: 718–723
   PubMed Web of Science ®Google Scholar
• Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol 1981; 11: 261–274
   PubMed Web of Science ®Google Scholar
• Ohel G, Kaneti H, Schenker J G. Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol 1983; 15: 278–286
   PubMed Web of Science ®Google Scholar
• Martelli H, Patte C. [Gonadal tumours in children]. Arch Pediatr 2003; 10: 246–250
   PubMed Web of Science ®Google Scholar
• Merras-Salmio L, Vettenranta K, Mottonen M, Heikinheimo M. Ovarian granulosa cell tumors in childhood. Pediatr Hematol Oncol 2002; 19: 145–156
   PubMed Web of Science ®Google Scholar
• Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994; 52: 50–55
   PubMed Web of Science ®Google Scholar
• Plantaz D, Flamant F, Vassal G, Chappuis J P, Baranzelli M C, Bouffet E, Dyon J F, Armari C, Bost M. [Granulosa cell tumors of the ovary in children and adolescents. Multicenter retrospective study in 40 patients aged 7 months to 22 years]. Arch Fr Pediatr 1992; 49: 793–798
   PubMedGoogle Scholar
• Costa M J, Walls J, Ames P, Roth L M. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 1996; 27: 274–281
   PubMed Web of Science ®Google Scholar
• Chadha S, Cornelisse C J, Schaberg A. Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors. Gynecol Oncol 1990; 36: 240–245
   PubMed Web of Science ®Google Scholar
• Hitchcock C L, Norris H J, Khalifa M A, Wargotz E S. Flow cytometric analysis of granulosa tumors. Cancer 1989; 64: 2127–2132
   PubMed Web of Science ®Google Scholar
• Suh K S, Silverberg S G, Rhame J G, Wilkinson D S. Granulosa cell tumor of the ovary. Histopathologic and flow cytometric analysis with clinical correlation. Arch Pathol Lab Med 1990; 114: 496–501
   PubMed Web of Science ®Google Scholar
• Klemi P J, Joensuu H, Salmi T. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Cancer 1990; 65: 1189–1193
   PubMed Web of Science ®Google Scholar
• King L A, Okagaki T, Gallup D G, Twiggs L B, Messing M J, Carson L F. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 1996; 61: 227–232
   PubMed Web of Science ®Google Scholar
• Kim K, Lindstrom M J, Gould M N. Regions of H- and K-ras that provide organ specificity/potency in mammary cancer induction. Cancer Res 2002; 62: 1241–1245
   PubMed Web of Science ®Google Scholar
• Makrigiannakis A, Amin K, Coukos G, Tilly J L, Coutifaris C. Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary. J Clin Endocrinol Metab 2000; 85: 449–459
   PubMed Web of Science ®Google Scholar
• Coppes M J, Ye Y, Rackley R, Zhao X L, Liefers G J, Casey G, Williams B R. Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. Cancer Res 1993; 53: 2712–2714
   PubMed Web of Science ®Google Scholar
• Liu F S, Ho E S, Lai C R, Chen J T, Shih R T, Yang C H, Tsao C M. Overexpression of p53 is not a feature of ovarian granulosa cell tumors. Gynecol Oncol 1996; 61: 50–53
   PubMed Web of Science ®Google Scholar
• Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Rohlke P, Loning T. p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer l995; 64: 52–59
   PubMed Web of Science ®Google Scholar
• Chu S, Rushdi S, Zumpe E T, Mamers P, Healy D L, Jobling T, Burger H G, Fuller P J. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod 2002; 8: 426–433
   PubMed Web of Science ®Google Scholar
• Healy D L, Burger H G, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day A J, Rome R, Campbell J J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 1993; 329: 1539–1542
   PubMed Web of Science ®Google Scholar
• Kotlar T J, Young R H, Albanese C, Crowley W F, Jr, Scully R E, Jameson J L. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J Clin Endocrinol Metab 1997; 82: 1020–1026
   PubMed Web of Science ®Google Scholar
• Fragoso M C, Latronico A C, Carvalho F M, Zerbini M C, Marcondes J A, Araujo L M, Lando V S, Frazzatto E T, Mendonca B B, Villares S M. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 1998; 83: 2074–2078
   PubMed Web of Science ®Google Scholar
• Ligtenberg M J, Siers M, Themmen A P, Hanselaar T G, Willemsen W, Brunner H G. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J Clin Endocrinol Metab 1999; 84: 2233–2234
   PubMed Web of Science ®Google Scholar
• Chien J, Wong E, Nikes E, Noble M J, Pantazis C G, Shah G V. Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells. Oncogene 1999; 18: 3376–3382
   PubMed Web of Science ®Google Scholar
• Kalfa N, Ecochard A, Patte C, Duvillard P, Audran F, Pienkowski C, Thibaud E, Brauner R, Lecointre C, Plantaz D, et al. Activating utations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor. J Clin Endocrinol Metab 2006; 91: 1842–1847
   PubMed Web of Science ®Google Scholar
• Regnauld K, Nguyen Q D, Vakaet L, Bruyneel E, Launay J M, Endo T, Mareel M, Gespach C, Emami S. G-protein alpha(olf) subunit promotes cellular invasion, survival, and neuroendocrine differentiation in digestive and urogenital epithelial cells. Oncogene 2002; 21: 4020–4031
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Springett G M, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman D E, Graybiel A M. A family of cAMP-binding proteins that directly activate Rap1. Science 1998; 282: 2275–2279
   PubMed Web of Science ®Google Scholar
• de Rooij J, Rehmann H, van Triest M, Cool R H, Wittinghofer A, Bos J L. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 2000; 275: 20829–20836
   PubMed Web of Science ®Google Scholar
• Prueitt R L, Zinn A R. A fork in the road to fertility. Nat Genet 2001; 27: 132–134
   PubMed Web of Science ®Google Scholar
• Cocquet J, De Baere E, Gareil M, Pannetier M, Xia X, Fellous M, Veitia R A. Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res 2003; 101: 206–211
   PubMed Web of Science ®Google Scholar
• Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M, et al. Evolution and expression of FOXL2. J Med Genet 2002; 39: 916–921
   PubMed Web of Science ®Google Scholar
• Schmidt D, Ovitt C E, Anlag K, Fehsenfeld S, Gredsted L, Treier A C, Treier M. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004; 131: 933–942
   PubMed Web of Science ®Google Scholar
• Kalfa N, Philibert P, Patte C, Ecochard A, Duvillard P, Baldet P, Jaubert F, Fellous M, Sultan C. Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril 2007; 87: 896–901
   PubMed Web of Science ®Google Scholar
• Lee K, Pisarska M D, Ko J J, Kang Y, Yoon S, Ryou S M, Cha K Y, Bae J. Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis. Biochem Biophys Res Commun 2005; 336: 876–881
   PubMed Web of Science ®Google Scholar
• Powell J L, Connor G P, Henderson G S. Management of recurrent juvenile granulosa cell tumor of the ovary. Gynecol Oncol 2001; 81: 113–116
   PubMed Web of Science ®Google Scholar